Literature DB >> 2154976

Tumor necrosis factor-alpha enhances inhibitory effects of interleukin-1 beta on Leydig cell steroidogenesis.

J H Calkins1, H Guo, M M Sigel, T Lin.   

Abstract

Human recombinant tumor necrosis factor-alpha (rTNF alpha) alone (up to 1000 units/ml) did not alter either basal or human chorionic gonadotropin (hCG)-induced testosterone formation in primary culture of rat Leydig cells. However, concomitant addition of rTNF alpha with human recombinant interleukin-1 beta (rIL-1 beta) enhanced the inhibitory effects of rIL-1 beta. The rIL-1 beta dose response curve was shifted to the left (IC50 changed from 1 ng/ml to 0.3 ng/ml). Even though rTNF alpha had no effect on testosterone formation, hCG-stimulated cyclic AMP formation was inhibited by rTNF alpha in a dose dependent manner. In the presence of both rTNF alpha and rIL-1 beta, hCG-induced cyclic AMP formation and binding of [125I]-hCG to Leydig cells were further inhibited. Testicular macrophages represent about 20% of the interstitial cells. TNF alpha and IL-1 may be produced locally by interstitial macrophages and have paracrine effects on Leydig cell function.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154976     DOI: 10.1016/0006-291x(90)91009-h

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Role of cytokines in testicular function.

Authors:  D B Hales; T Diemer; K H Hales
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

2.  TNF-α-mediated suppression of Leydig cell steroidogenesis involves DAX-1.

Authors:  Mohanraj Sadasivam; Balamurugan Ramatchandirin; Sivasangari Balakrishnan; Chidambaram Prahalathan
Journal:  Inflamm Res       Date:  2015-06-06       Impact factor: 4.575

3.  HDAC7 modulates TNF-α-mediated suppression of Leydig cell steroidogenesis.

Authors:  Mohanraj Sadasivam; Balamurugan Ramatchandirin; Sivasangari Balakrishnan; Chidambaram Prahalathan
Journal:  Mol Cell Biochem       Date:  2015-04-28       Impact factor: 3.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.